Epilepsy and brain inflammation

Experimental Neurology

Volumn 244, Issue , 2013, Pages 11-21

  Vezzani, Annamaria ^a   Aronica, Eleonora ^b,c   Mazarati, Andrey ^d   Pittman, Quentin J ^e  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c STICHTING EPILEPSIE INSTELLINGEN NEDERLAND SEIN   (Netherlands)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALGARY   (Canada)

Author keywords

Blood brain barrier; Experimental models of epilepsy; Glia; Leukocytes; Pharmacoresistance; Seizures

Indexed keywords

ANTICONVULSIVE AGENT; ANTIINFLAMMATORY AGENT; CELL ADHESION MOLECULE; CHEMOKINE; COMPLEMENT FACTOR; CYTOKINE; FLUOXETINE; GLUTAMATE RECEPTOR; GLUTAMATE TRANSPORTER; GLUTAMINE; NEUROTRANSMITTER; NEUROTROPHIC FACTOR; POTASSIUM CHANNEL; PROSTAGLANDIN;

AUTISM; AUTOCRINE EFFECT; BRAIN INJURY; BRAIN TISSUE; CELL COMMUNICATION; CELL INTERACTION; CELL SURVIVAL; COMORBIDITY; DEPRESSION; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; ENCEPHALITIS; EPILEPSY; EPILEPTOGENESIS; FEBRILE CONVULSION; GLIA CELL; HUMAN; MEMORY DISORDER; MICROGLIA; NERVE CELL EXCITABILITY; NERVE CELL STIMULATION; NERVOUS SYSTEM INJURY; NEUROMODULATION; NONHUMAN; PARACRINE SIGNALING; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; RECURRENT DISEASE; REVIEW; SEIZURE; SEIZURE THRESHOLD;

ANIMALS; ENCEPHALITIS; EPILEPSY; HUMANS; NEUROGLIA;

EID: 84877606780     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2011.09.033     Document Type: Review

References (200)

1. Akassoglou K., Probert L., Kontogeorgos G., Kollias G. Astrocyte-specific but not neuron-specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice. J. Immunol. 1997, 158:438-445.
2. Akin D., Ravizza T., Maroso M., Carcak N., Eryigit T., Vanzulli I., Gulhan Aker R., Vezzani A., Onat F.Y. IL-1beta is induced in reactive astrocytes in the somatosensory cortex of rats with genetic absence epilepsy at the onset of spike-and-wave discharges, and contributes to their occurrence. Neurobiol. Dis. 2011, 44(3):259-269.
3. Alapirtti T., Rinta S., Hulkkonen J., Makinen R., Keranen T., Peltola J. Interleukin-6, interleukin-1 receptor antagonist and interleukin-1beta production in patients with focal epilepsy: a video-EEG study. J. Neurol. Sci. 2009, 280:94-97.
4. Allan S.M., Rothwell N.J. Cytokines and acute neurodegeneration. Nat. Rev. Neurosci. 2001, 2:734-744.
5. Alvarez-Baron E., Bien C.G., Schramm J., Elger C.E., Becker A.J., Schoch S. Autoantibodies to Munc18, cerebral plasma cells and B-lymphocytes in Rasmussen encephalitis. Epilepsy Res. 2008, 80:93-97.
6. Andersson A., Covacu R., Sunnemark D., Danilov A.I., Dal Bianco A., Khademi M., Wallstrom E., Lobell A., Brundin L., Lassmann H., Harris R.A. Pivotal advance: HMGB1 expression in active lesions of human and experimental multiple sclerosis. J. Leukoc. Biol. 2008, 84:1248-1255.
7. Arancio O., Zhang H.P., Chen X., Lin C., Trinchese F., Puzzo D., Liu S., Hegde A., Yan S.F., Stern A., Luddy J.S., Lue L.F., Walker D.G., Roher A., Buttini M., Mucke L., Li W., Schmidt A.M., Kindy M., Hyslop P.A., Stern D.M., Du Yan S.S. RAGE potentiates Abeta-induced perturbation of neuronal function in transgenic mice. EMBO J. 2004, 23:4096-4105.
8. Aronica E., Crino P.B. Inflammation in epilepsy: clinical observations. Epilepsia 2011, 52(Suppl. 3):26-32.
9. Aronica E., Gorter J.A. Gene expression profile in temporal lobe epilepsy. Neuroscientist 2007, 13:100-108.
10. Aronica E., Boer K., van Vliet E.A., Redeker S., Baayen J.C., Spliet W.G., van Rijen P.C., Troost D., da Silva F.H., Wadman W.J., Gorter J.A. Complement activation in experimental and human temporal lobe epilepsy. Neurobiol. Dis. 2007, 26:497-511.
11. Aronica E., Fluiter K., Iyer A., Zurolo E., Vreijling J., van Vliet E.A., Baayen J.C., Gorter J.A. Expression pattern of miR-146a, an inflammation-associated microRNA, in experimental and human temporal lobe epilepsy. Eur. J. Neurosci. 2010, 31:1100-1107.
12. Asano T., Ichiki K., Koizumi S., Kaizu K., Hatori T., Fujino O., Mashiko K., Sakamoto Y., Miyasho T., Fukunaga Y. IL-8 in cerebrospinal fluid from children with acute encephalopathy is higher than in that from children with febrile seizure. Scand. J. Immunol. 2010, 71:447-451.
13. Atladottir H.O., Thorsen P., Ostergaard L., Schendel D.E., Lemcke S., Abdallah M., Parner E.T. Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders. J. Autism Dev. Disord. 2010, 40:1423-1430.
14. Auvin S., Porta N., Nehlig A., Lecointe C., Vallee L., Bordet R. Inflammation in rat pups subjected to short hyperthermic seizures enhances brain long-term excitability. Epilepsy Res. 2009, 86:124-130.
15. Auvin S., Mazarati A., Shin D. Inflammation enhances epileptogenesis in immature rat brain. Neurobiol. Dis. 2010, 40:303-310.
16. Auvin S., Shin D., Mazarati A., Sankar R. Inflammation induced by LPS enhances epileptogenesis in immature rat and may be partially reversed by IL1RA. Epilepsia 2010, 51(Suppl. 3):34-38.
17. Baharnoori M., Brake W.G., Srivastava L.K. Prenatal immune challenge induces developmental changes in the morphology of pyramidal neurons of the prefrontal cortex and hippocampus in rats. Schizophr. Res. 2009, 107:99-109.
18. Ballabh P., Braun A., Nedergaard M. The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol. Dis. 2004, 16:1-13.
19. Balosso S., Maroso M., Sanchez-Alavez M., Ravizza T., Frasca A., Bartfai T., Vezzani A. A novel non-transcriptional pathway mediates the proconvulsive effects of interleukin-1beta. Brain 2008, 131:3256-3265.
20. Balosso S., Ravizza T., Pierucci M., Calcagno E., Invernizzi R.W., Di Giovanni G., Esposito E., Vezzani A. Molecular and functional interactions between TNF-alpha receptors and the glutamatergic system in the mouse hippocampus: implications for seizure susceptibility. Neuroscience 2009, 161:293-300.
21. Banati R.B. Visualising microglial activation in vivo. Glia 2002, 40:206-217.
22. Baram T.Z., Shinnar S. Febrile Seizures 2002, Academic Press.
23. Bauer J., Bien C.G. Encephalitis and epilepsy. Semin. Immunopathol. 2009, 31:537-544.
24. Bauer J., Elger C.E., Hans V.H., Schramm J., Urbach H., Lassmann H., Bien C.G. Astrocytes are a specific immunological target in Rasmussen's encephalitis. Ann. Neurol. 2007, 62:67-80.
25. Bauer S., Cepok S., Todorova-Rudolph A., Nowak M., Koller M., Lorenz R., Oertel W.H., Rosenow F., Hemmer B., Hamer H.M. Etiology and site of temporal lobe epilepsy influence postictal cytokine release. Epilepsy Res. 2009, 86:82-88.
26. Ben-Ari Y. Basic developmental rules and their implications for epilepsy in the immature brain. Epileptic Disord. 2006, 8:91-102.
27. Ben-Ari Y., Holmes G.L. Effects of seizures on developmental processes in the immature brain. Lancet Neurol. 2006, 5:1055-1063.
28. Bianchi M.E., Manfredi A.A. High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity. Immunol. Rev. 2007, 220:35-46.
29. Bien C.G., Bauer J., Deckwerth T.L., Wiendl H., Deckert M., Wiestler O.D., Schramm J., Elger C.E., Lassmann H. Destruction of neurons by cytotoxic T cells: a new pathogenic mechanism in Rasmussen's encephalitis. Ann. Neurol. 2002, 51:311-318.
30. Bien C.G., Urbach H., Schramm J., Soeder B.M., Becker A.J., Voltz R., Vincent A., Elger C.E. Limbic encephalitis as a precipitating event in adult-onset temporal lobe epilepsy. Neurology 2007, 69:1236-1244.
31. Bilbo S.D., Biedenkapp J.C., Der-Avakian A., Watkins L.R., Rudy J.W., Maier S.F. Neonatal infection-induced memory impairment after lipopolysaccharide in adulthood is prevented via caspase-1 inhibition. J. Neurosci. 2005, 25:8000-8009.
32. Blatteis C.M. The onset of fever: new insights into its mechanism. Prog. Brain Res. 2007, 162:3-14.
33. Blumcke I., Thom M., Aronica E., Armstrong D.D., Vinters H.V., Palmini A., Jacques T.S., Avanzini G., Barkovich A.J., Battaglia G., Becker A., Cepeda C., Cendes F., Colombo N., Crino P., Cross J.H., Delalande O., Dubeau F., Duncan J., Guerrini R., Kahane P., Mathern G., Najm I., Ozkara C., Raybaud C., Represa A., Roper S.N., Salamon N., Schulze-Bonhage A., Tassi L., Vezzani A., Spreafico R. The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc task force of the ILAE Diagnostic Methods Commission. Epilepsia 2010, 52:158-174.
34. Boer K., Spliet W.G., van Rijen P.C., Redeker S., Troost D., Aronica E. Evidence of activated microglia in focal cortical dysplasia. J. Neuroimmunol. 2006, 173:188-195.
35. Boer K., Jansen F., Nellist M., Redeker S., van den Ouweland A.M., Spliet W.G., van Nieuwenhuizen O., Troost D., Crino P.B., Aronica E. Inflammatory processes in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex. Epilepsy Res. 2008, 78:7-21.
36. Boer K., Crino P.B., Gorter J.A., Nellist M., Jansen F.E., Spliet W.G.M., van Rijen P.C., Wittink F.R.A., Breit T.M., Troost D., Wadman W.J., Aronic E. Gene expression analysis of tuberous sclerosis complex cortical tubers reveals increased expression of adhesion and inflammatory factors. Brain Pathol. 2010, 20:704-719.
37. Boso M., Emanuele E., Minoretti P., Arra M., Politi P., Ucelli di Nemi S., Barale F. Alterations of circulating endogenous secretory RAGE and S100A9 levels indicating dysfunction of the AGE-RAGE axis in autism. Neurosci. Lett. 2006, 410:169-173.
38. Boulanger L.M. Immune proteins in brain development and synaptic plasticity. Neuron 2009, 64:93-109.
39. Brambilla D., Franciosi S., Opp M.R., Imeri L. Interleukin-1 inhibits firing of serotonergic neurons in the dorsal raphe nucleus and enhances GABAergic inhibitory post-synaptic potentials. Eur. J. Neurosci. 2007, 26:1862-1869.
40. Bremmer M.A., Beekman A.T., Deeg D.J., Penninx B.W., Dik M.G., Hack C.E., Hoogendijk W.J. Inflammatory markers in late-life depression: results from a population-based study. J. Affect. Disord. 2008, 106:249-255.
41. Bruce T.O. Comorbid depression in rheumatoid arthritis: pathophysiology and clinical implications. Curr. Psychiatry Rep. 2008, 10:258-264.
42. Brunson K.L., Avishai-Eliner S., Baram T.Z. ACTH treatment of infantile spasms: mechanisms of its effects in modulation of neuronal excitability. Int. Rev. Neurobiol. 2002, 49:185-197.
43. Butler T., Masanori I.M., Vallabhajosula S., Pan H., Dhawan V., Labar D., Gerard D., Stern E., Goldsmith S., Bazil C.W., Greenberg E., Pervez F., Provenzano F., Eidelberg D., Tsirka S.E., Gilliam F., Silbersweig D. Imaging inflammation in human focal epilepsy. Ann. Neurol. 2009, 66:S70.
44. Butler T., Ichise M., Teich A.F., Gerard E., Osborne J., French J., Devinsky O., Kuzniecky R., Gilliam F., Pervez F., Provenzano F., Goldsmith S., Vallabhajosula S., Stern E., Silbersweig D. Imaging inflammation in a patient with epilepsy due to focal cortical dysplasia. J. Neuroimaging 2011, 10.1111/j.1552-6569.2010.00572.x.
45. Cacheaux L.P., Ivens S., David Y., Lakhter A.J., Bar-Klein G., Shapira M., Heinemann U., Friedman A., Kaufer D. Transcriptome profiling reveals TGF-beta signaling involvement in epileptogenesis. J. Neurosci. 2009, 29:8927-8935.
46. Carpentier P.A., Palmer T.D. Immune influence on adult neural stem cell regulation and function. Neuron 2009, 64:79-92.
47. Carroll B.J., Cassidy F., Naftolowitz D., Tatham N.E., Wilson W.H., Iranmanesh A., Liu P.Y., Veldhuis J.D. Pathophysiology of hypercortisolism in depression. Acta Psychiatr. Scand. Suppl. 2007, 90-103.
48. Choi J., Koh S. Role of brain inflammation in epileptogenesis. Yonsei Med. J. 2008, 49:1-18.
49. Choi J., Nordli D.R., Alden T.D., DiPatri A., Laux L., Kelley K., Rosenow J., Schuele S.U., Rajaram V., Koh S. Cellular injury and neuroinflammation in children with chronic intractable epilepsy. J. Neuroinflammation 2009, 6:38.
50. Clancy B., Finlay B.L., Darlington R.B., Anand K.J. Extrapolating brain development from experimental species to humans. Neurotoxicology 2007, 28:931-937.
51. Clarke D.F., Roberts W., Daraksan M., Dupuis A., McCabe J., Wood H., Snead O.C., Weiss S.K. The prevalence of autistic spectrum disorder in children surveyed in a tertiary care epilepsy clinic. Epilepsia 2005, 46:1970-1977.
52. Dantzer R. Cytokine, sickness behavior, and depression. Neurol. Clin. 2006, 24:441-460.
53. Dantzer R., Kelley K.W. Stress and immunity: an integrated view of relationships between the brain and the immune system. Life Sci. 1989, 44:1995-2008.
54. Dantzer R., O'Connor J.C., Lawson M.A., Kelley K.W. Inflammation-associated depression: from serotonin to kynurenine. Psychoneuroendocrinology 2011, 36:426-436.
55. De Simoni M.G., Perego C., Ravizza T., Moneta D., Conti M., Marchesi F., De Luigi A., Garattini S., Vezzani A. Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus. Eur. J. Neurosci. 2000, 12:2623-2633.
56. Dhote F., Peinnequin A., Carpentier P., Baille V., Delacour C., Foquin A., Lallement G., Dorandeu F. Prolonged inflammatory gene response following soman-induced seizures in mice. Toxicology 2007, 238:166-176.
57. Dobbing J., Sands J. Quantitative growth and development of human brain. Arch. Dis. Child. 1973, 48:757-767.
58. Dubé C., Vezzani A., Behrens M., Bartfai T., Baram T.Z. Interleukin-1beta contributes to the generation of experimental febrile seizures. Ann. Neurol. 2005, 57:152-155.
59. Dubé C.M., Brewster A.L., Baram T.Z. Febrile seizures: mechanisms and relationship to epilepsy. Brain Dev. 2006, 31:366-371.
60. Dubé C., Richichi C., Bender R.A., Chung G., Litt B., Baram T.Z. Temporal lobe epilepsy after experimental prolonged febrile seizures: prospective analysis. Brain 2006, 129:911-922.
61. Dubé C.M., Ravizza T., Hamamura M., Zha Q., Keebaugh A., Fok K., Andres A.L., Nalcioglu O., Obenaus A., Vezzani A., Baram T.Z. Epileptogenesis provoked by prolonged experimental febrile seizures: mechanisms and biomarkers. J. Neurosci. 2010, 30:7484-7494.
62. Duchowny M., Jayakar P., Levin B. Aberrant neural circuits in malformations of cortical development and focal epilepsy. Neurology 2000, 55:423-428.
63. Dunn A.J., Swiergiel A.H. Effects of interleukin-1 and endotoxin in the forced swim and tail suspension tests in mice. Pharmacol. Biochem. Behav. 2005, 81:688-693.
64. Emanuele E., Boso M., Brondino N., Pietra S., Barale F., Ucelli di Nemi S., Politi P. Increased serum levels of high mobility group box 1 protein in patients with autistic disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 2010, 34:681-683.
65. Enstrom A.M., Onore C.E., Van de Water J.A., Ashwood P. Differential monocyte responses to TLR ligands in children with autism spectrum disorders. Brain Behav. Immun. 2010, 24:64-71.
66. Eriksson C., Tehranian R., Iverfeldt K., Winblad B., Schultzberg M. Increased expression of mRNA encoding interleukin-1beta and caspase-1, and the secreted isoform of interleukin-1 receptor antagonist in the rat brain following systemic kainic acid administration. J. Neurosci. Res. 2000, 60:266-279.
67. Fabene P.F., Mora G.N., Martinello M., Rossi B., Merigo F., Ottoboni L., Bach S., Angiari S., Benati D., Chakir A., Zanetti L., Schio F., Osculati A., Marzola P., Nicolato E., Homeister J.W., Xia L., Lowe J.B., McEver R.P., Osculati F., Sbarbati A., Butcher E.C., Constantin G. A role for leukocyte-endothelial adhesion mechanisms in epilepsy. Nat. Med. 2008, 14:1377-1383.
68. Fourgeaud L., Boulanger L.M. Role of immune molecules in the establishment and plasticity of glutamatergic synapses. Eur. J. Neurosci. 2010, 32:207-217.
69. Friedman A., Dingledine R. Molecular cascades that mediate the influence of inflammation on epilepsy. Epilepsia 2011, 52(Suppl. 3):33-39.
70. Friedman A., Kaufer D., Heinemann U. Blood-brain barrier breakdown-inducing astrocytic transformation: novel targets for the prevention of epilepsy. Epilepsy Res. 2009, 85:142-149.
71. Galic M.A., Riazi K., Heida J.G., Mouihate A., Fournier N.M., Spencer S.J., Kalynchuk L.E., Teskey G.C., Pittman Q.J. Postnatal inflammation increases seizure susceptibility in adult rats. J. Neurosci. 2008, 28:6904-6913.
72. Galic M.A., Riazi K., Henderson A.K., Tsutsui S., Pittman Q.J. Viral-like brain inflammation during development causes increased seizure susceptibility in adult rats. Neurobiol. Dis. 2009, 36:343-351.
73. Garcia-Morales I., de la Pena Mayor P., Kanner A.M. Psychiatric comorbidities in epilepsy: identification and treatment. Neurologist 2008, 14:S15-S25.
74. Gibbs S.A., Scantlebury M.H., Awad P., Lema P., Essouma J.B., Parent M., Descarries L., Carmant L. Hippocampal atrophy and abnormal brain development following a prolonged hyperthermic seizure in the immature rat with a focal neocortical lesion. Neurobiol. Dis. 2008, 32:176-182.
75. Giovagnoli A.R., Avanzini G. Learning and memory impairment in patients with temporal lobe epilepsy: relation to the presence, type, and location of brain lesion. Epilepsia 1999, 40:904-911.
76. Giulian D., Woodward J., Young D.G., Krebs J.F., Lachman L.B. Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization. J. Neurosci. 1988, 8:2485-2490.
77. Goddard C.A., Butts D.A., Shatz C.J. Regulation of CNS synapses by neuronal MHC class I. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:6828-6833.
78. Golan H., Levav T., Mendelsohn A., Huleihel M. Involvement of tumor necrosis factor alpha in hippocampal development and function. Cereb. Cortex 2004, 14:97-105.
79. Gorter J.A., van Vliet E.A., Aronica E., Breit T., Rauwerda H., Lopes da Silva F.H., Wadman W.J. Potential new antiepileptogenic targets indicated by microarray analysis in a rat model for temporal lobe epilepsy. J. Neurosci. 2006, 26:11083-11110.
80. Goshen I., Yirmiya R. Interleukin-1 (IL-1): a central regulator of stress responses. Front. Neuroendocrinol. 2009, 30:30-45.
81. Guo J.Y., Li C.Y., Ruan Y.P., Sun M., Qi X.L., Zhao B.S., Luo F. Chronic treatment with celecoxib reverses chronic unpredictable stress-induced depressive-like behavior via reducing cyclooxygenase-2 expression in rat brain. Eur. J. Pharmacol. 2009, 612:54-60.
82. Harré E.M., Galic M.A., Mouihate A., Noorbakhsh F., Pittman Q.J. Neonatal inflammation produces selective behavioural deficits and alters N-methyl-d-aspartate receptor subunit mRNA in the adult rat brain. Eur. J. Neurosci. 2008, 27:644-653.
83. Hayakawa K., Arai K., Lo E.H. Role of ERK map kinase and CRM1 in IL-1beta-stimulated release of HMGB1 from cortical astrocytes. Glia 2010, 58:1007-1015.
84. Heida J.G., Pittman Q.J. Causal links between brain cytokines and experimental febrile convulsions in the rat. Epilepsia 2005, 46:1906-1913.
85. Heida J.G., Boisse L., Pittman Q.J. Lipopolysaccharide-induced febrile convulsions in the rat: short-term sequelae. Epilepsia 2004, 45:1317-1329.
86. Heida J.G., Teskey G.C., Pittman Q.J. Febrile convulsions induced by the combination of lipopolysaccharide and low-dose kainic acid enhance seizure susceptibility, not epileptogenesis, in rats. Epilepsia 2005, 46:1898-1905.
87. Heida J.G., Moshé S.L., Pittman Q.J. The role of interleukin-1beta in febrile seizures. Brain Dev. 2009, 31:388-393.
88. Helminen M., Vesikari T. Increased interleukin-1 (IL-1) production from LPS-stimulated peripheral blood monocytes in children with febrile convulsions. Acta Paediatr. Scand. 1990, 79:810-816.
89. Hirvonen J., Kreisl W., Fujita M., Dustin I., Miranda S., Zhang Y., Morse C., Pike V.R., Innis R., Theodore W.H. Increased In Vivo Expression of an Inflammatory Marker in Temporal Lobe Epilepsy 2010, American Epilepsy Society, S. Antonio (TX), (Abst 3.230).
90. Holmes G.L., Khazipov R., Ben-Ari Y. Seizure-induced damage in the developing human: relevance of experimental models. Prog. Brain Res. 2002, 135:321-334.
91. Holtzman D., Obana K., Olson J. Hyperthermia-induced seizures in the rat pup: a model for febrile convulsions in children. Science 1981, 213:1034-1036.
92. Hu S., Sheng W.S., Ehrlich L.C., Peterson P.K., Chao C.C. Cytokine effects on glutamate uptake by human astrocytes. Neuroimmunomodulation 2000, 7:153-159.
93. Ichiyama T., Nishikawa M., Yoshitomi T., Hayashi T., Furukawa S. Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 in cerebrospinal fluid from children with prolonged febrile seizures. Comparison with acute encephalitis/encephalopathy. Neurology 1998, 50:407-411.
94. Irani S.R., Bera K., Waters P., Zuliani L., Maxwell S., Zandi M.S., Friese M.A., Galea I., Kullmann D.M., Beeson D., Lang B., Bien C.G., Vincent A. N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 2010, 133:1655-1667.
95. Iyer A., Zurolo E., Spliet W.G., van Rijen P.C., Baayen J.C., Gorter J.A., Aronica E. Evaluation of the innate and adaptive immunity in type I and type II focal cortical dysplasias. Epilepsia 2010, 51:1763-1773.
96. Iyer A.M., Zurolo E., Boer K., Baayen J.C., Giangaspero F., Arcella A., Di Gennaro G.C., Esposito V., Spliet W.G.M., van Rijen P.C., Troost D., Gorter J.A., Aronica E. Tissue plasminogen activator and urokinase plasminogen activator in human epileptogenic pathologies. Neuroscience 2010, 19:929-945.
97. Judge S.J., Ingram C.D., Gartside S.E. Moderate differences in circulating corticosterone alter receptor-mediated regulation of 5-hydroxytryptamine neuronal activity. J. Psychopharmacol. 2004, 18:475-483.
98. Jung K.H., Chu K., Lee S.T., Kim J., Sinn D.I., Kim J.M., Park D.K., Lee J.J., Kim S.U., Kim M., Lee S.K., Roh J.K. Cyclooxygenase-2 inhibitor, celecoxib, inhibits the altered hippocampal neurogenesis with attenuation of spontaneous recurrent seizures following pilocarpine-induced status epilepticus. Neurobiol. Dis. 2006, 23:237-246.
99. Kanemoto K., Kawasaki J., Yuasa S., Kumaki T., Tomohiro O., Kaji R., Nishimura M. Increased frequency of interleukin-1beta-511T allele in patients with temporal lobe epilepsy, hippocampal sclerosis, and prolonged febrile convulsion. Epilepsia 2003, 44:796-799.
100. Karnam H.B., Zhou J.L., Huang L.T., Zhao Q., Shatskikh T., Holmes G.L. Early life seizures cause long-standing impairment of the hippocampal map. Exp. Neurol. 2009, 217:378-387.
101. Karvelas G., Lortie A., Scantlebury M.H., Duy P.T., Cossette P., Carmant L. A retrospective study on aetiology based outcome of infantile spasms. Seizure 2009, 18:197-201.
102. Kira R., Torisu H., Takemoto M., Nomura A., Sakai Y., Sanefuji M., Sakamoto K., Matsumoto S., Gondo K., Hara T. Genetic susceptibility to simple febrile seizures: interleukin-1beta promoter polymorphisms are associated with sporadic cases. Neurosci. Lett. 2005, 384:239-244.
103. Kira R., Ishizaki Y., Torisu H., Sanefuji M., Takemoto M., Sakamoto K., Matsumoto S., Yamaguchi Y., Yukaya N., Sakai Y., Gondo K., Hara T. Genetic susceptibility to febrile seizures: case-control association studies. Brain Dev. 2010, 32:57-63.
104. Kulkarni S.K., Dhir A. Cyclooxygenase in epilepsy: from perception to application. Drugs Today (Barc.) 2009, 45:135-154.
105. Kumar A., Chugani H.T., Luat A., Asano E., Sood S. Epilepsy surgery in a case of encephalitis: use of 11C-PK11195 positron emission tomography. Pediatr. Neurol. 2008, 38:439-442.
106. Lahat E., Livne M., Barr J., Katz Y. Interleukin-1beta levels in serum and cerebrospinal fluid of children with febrile seizures. Pediatr. Neurol. 1997, 17:34-36.
107. Lucas S.M., Rothwell N.J., Gibson R.M. The role of inflammation in CNS injury and disease. Br. J. Pharmacol. 2006, 147(Suppl. 1):S232-S240.
108. Lukasiuk K., Dabrowski M., Adach A., Pitkanen A. Epileptogenesis-related genes revisited. Prog. Brain Res. 2006, 158:223-241.
109. Majores M., Eils J., Wiestler O.D., Becker A.J. Molecular profiling of temporal lobe epilepsy: comparison of data from human tissue samples and animal models. Epilepsy Res. 2004, 60:173-178.
110. Manji H.K., Drevets W.C., Charney D.S. The cellular neurobiology of depression. Nat. Med. 2001, 7:541-547.
111. Mantegazza R., Bernasconi P., Baggi F., Spreafico R., Ragona F., Antozzi C., Bernardi G., Granata T. Antibodies against GluR3 peptides are not specific for Rasmussen's encephalitis but are also present in epilepsy patients with severe, early onset disease and intractable seizures. J. Neuroimmunol. 2002, 131:179-185.
112. Marchi N., Teng Q., Ghosh C., Fan Q., Nguyen M.T., Desai N.K., Bawa H., Rasmussen P., Masaryk T.K., Janigro D. Blood-brain barrier damage, but not parenchymal white blood cells, is a hallmark of seizure activity. Brain Res. 2010, 1353:176-186.
113. Marcon J., Gagliardi B., Balosso S., Maroso M., Noé F., Morin M., Lerner-Natoli M., Vezzani A., Ravizza T. Age-dependent vascular changes induced by status epilepticus in rat forebrain: implications for epileptogenesis. Neurobiol. Dis. 2009, 34:121-132.
114. Maroso M., Balosso S., Ravizza T., Liu J., Aronica E., Iyer A.M., Rossetti C., Molteni M., Casalgrandi M., Manfredi A.A., Bianchi M.E., Vezzani A. Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nat. Med. 2010, 16:413-419.
115. Maroso M., Balosso S., Ravizza T., Iori V., Wright C.I., French J., Vezzani A. Interleukin-1beta biosynthesis inhibition reduces acute seizures and drug resistant chronic epileptic activity in mice. Neurotherapeutics 2011, 8:304-315.
116. Maroso M., Balosso S., Ravizza T., Liu J., Bianchi M.E., Vezzani A. IL-1R1/TLR signaling in epilepsy: the focus on IL-1beta and HMGB1. J. Intern. Med. 2011, 27. (Jul, Epub ahead of print). 10.1111/j.1365-2796.2011.02431.x.
117. Matsuo M., Sasaki K., Ichimaru T., Nakazato S., Hamasaki Y. Increased IL-1beta production from dsRNA-stimulated leukocytes in febrile seizures. Pediatr. Neurol. 2006, 35:102-106.
118. Mazarati A., Siddarth P., Baldwin R.A., Shin D., Caplan R., Sankar R. Depression after status epilepticus: behavioural and biochemical deficits and effects of fluoxetine. Brain 2008, 131:2071-2083.
119. Mazarati A.M., Shin D., Kwon Y.S., Bragin A., Pineda E., Tio D., Taylor A.N., Sankar R. Elevated plasma corticosterone level and depressive behavior in experimental temporal lobe epilepsy. Neurobiol. Dis. 2009, 34:457-461.
120. Mazarati A.M., Pineda E., Shin D., Tio D., Taylor A.N., Sankar R. Comorbidity between epilepsy and depression: role of hippocampal interleukin-1beta. Neurobiol. Dis. 2010, 37:461-467.
121. Mazarati A., Maroso M., Iori V., Vezzani A., Carli M. High-mobility group box-1 impairs memory in mice through both toll-like receptor 4 and receptor for advanced glycation end products. Exp. Neurol. 2011, 10.1016/j.expneurol.2011.08.012.
122. McClelland S., Dube C.M., Yang J., Baram T.Z. Epileptogenesis after prolonged febrile seizures: mechanisms, biomarkers and therapeutic opportunities. Neurosci. Lett. 2011.
123. Mendez M.F., Cummings J.L., Benson D.F. Depression in epilepsy. Significance and phenomenology. Arch. Neurol. 1986, 43:766-770.
124. Minami M., Kuraishi Y., Yamaguchi T., Nakai S., Hirai Y., Satoh M. Convulsants induce interleukin-1 beta messenger RNA in rat brain. Biochem. Biophys. Res. Commun. 1990, 171:832-837.
125. Molina-Hernandez M., Tellez-Alcantara N.P., Perez-Garcia J., Olivera-Lopez J.I., Jaramillo-Jaimes M.T. Antidepressant-like actions of minocycline combined with several glutamate antagonists. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32:380-386.
126. Nelson K.B., Ellenberg J.H. Predictors of epilepsy in children who have experienced febrile seizures. N. Engl. J. Med. 1976, 295:1029-1033.
127. Niehusmann P., Dalmau J., Rudlowski C., Vincent A., Elger C.E., Rossi J.E., Bien C.G. Diagnostic value of N-methyl-d-aspartate receptor antibodies in women with new-onset epilepsy. Arch. Neurol. 2009, 66:458-464.
128. NINDS/NIH NINDS epilepsy research benchmarks: benchmarks area III - prevent, limit, and reverse the co-morbidities associated with epilepsy http://www.ninds.nih.gov/funding/research/epilepsyweb/2007_benchmarks.ht.
129. Noebels J. A perfect storm: converging paths of epilepsy and Alzheimer's dementia intersect in the hippocampal formation. Epilepsia 2011, 52(Suppl. 1):39-46.
130. Oakley J.C., Kalume F., Yu F.H., Scheuer T., Catterall W.A. Temperature- and age-dependent seizures in a mouse model of severe myoclonic epilepsy in infancy. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:3994-3999.
131. Oby E., Janigro D. The blood-brain barrier and epilepsy. Epilepsia 2006, 47:1761-1774.
132. Okun E., Griffioen K.J., Mattson M.P. Toll-like receptor signaling in neural plasticity and disease. Trends Neurosci. 2011, 34:269-281.
133. O'Neill L.A., Bowie A.G. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat. Rev. Immunol. 2007, 7:353-364.
134. Pardo C.A., Vining E.P., Guo L., Skolasky R.L., Carson B.S., Freeman J.M. The pathology of Rasmussen syndrome: stages of cortical involvement and neuropathological studies in 45 hemispherectomies. Epilepsia 2004, 45:516-526.
135. Parsadaniantz S.M., Batsche E., Gegout-Pottie P., Terlain B., Gillet P., Netter P., Kerdelhue B. Effects of continuous infusion of interleukin 1 beta on corticotropin-releasing hormone (CRH), CRH receptors, proopiomelanocortin gene expression and secretion of corticotropin, beta-endorphin and corticosterone. Neuroendocrinology 1997, 65:53-63.
136. Parsey R.V., Oquendo M.A., Ogden R.T., Olvet D.M., Simpson N., Huang Y.Y., Van Heertum R.L., Arango V., Mann J.J. Altered serotonin 1A binding in major depression: a [carbonyl-C-11]WAY100635 positron emission tomography study. Biol. Psychiatry 2006, 59:106-113.
137. Patterson P.H. Immune involvement in schizophrenia and autism: etiology, pathology and animal models. Behav. Brain Res. 2009, 204:313-321.
138. Patterson P.H. Modeling autistic features in animals. Pediatr. Res. 2011, 69:34R-40R.
139. Pedrazzi M., Patrone M., Passalacqua M., Ranzato E., Colamassaro D., Sparatore B., Pontremoli S., Melloni E. Selective proinflammatory activation of astrocytes by high-mobility group box 1 protein signaling. J. Immunol. 2007, 179:8525-8532.
140. Pike K.E., Savage G. Memory profiling in mild cognitive impairment: can we determine risk for Alzheimer's disease?. J. Neuropsychol. 2008, 2:361-372.
141. Pineda E.A., Hensler J.G., Sankar R., Shin D., Burke T.F., Mazarati A.M. Plasticity of presynaptic and postsynaptic serotonin 1A receptors in an animal model of epilepsy-associated depression. Neuropsychopharmacology 2011, 36:1305-1316.
142. Pitkanen A. Therapeutic approaches to epileptogenesis-hope on the horizon. Epilepsia 2010, 51(Suppl. 3):2-17.
143. Rauvala H., Rouhiainen A. Physiological and pathophysiological outcomes of the interactions of HMGB1 with cell surface receptors. Biochim. Biophys. Acta 2010, 1799:164-170.
144. Ravizza T., Vezzani A. Status epilepticus induces time-dependent neuronal and astrocytic expression of interleukin-1 receptor type I in the rat limbic system. Neuroscience 2006, 137:301-308.
145. Ravizza T., Boer K., Redeker S., Spliet W.G., van Rijen P.C., Troost D., Vezzani A., Aronica E. The IL-1beta system in epilepsy-associated malformations of cortical development. Neurobiol. Dis. 2006, 24:128-143.
146. Ravizza T., Lucas S.M., Balosso S., Bernardino L., Ku G., Noé F., Malva J., Randle J.C., Allan S., Vezzani A. Inactivation of caspase-1 in rodent brain: a novel anticonvulsive strategy. Epilepsia 2006, 47:1160-1168.
147. Ravizza T., Gagliardi B., Noé F., Boer K., Aronica E., Vezzani A. Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy. Neurobiol. Dis. 2008, 29:142-160.
148. Ravizza T., Noé F., Zardoni D., Vaghi V., Sifringer M., Vezzani A. Interleukin converting enzyme inhibition impairs kindling epileptogenesis in rats by blocking astrocytic IL-1beta production. Neurobiol. Dis. 2008, 31:327-333.
149. Ravizza T., Balosso S., Vezzani A. Inflammation and prevention of epileptogenesis. Neurosci. Lett. 2011, 497:223-230.
150. Reid A.Y., Galic M.A., Teskey G.C., Pittman Q.J. Febrile seizures: current views and investigations. Can. J. Neurol. Sci. 2009, 36:679-686.
151. Riazi K., Galic M.A., Pittman Q.J. Contributions of peripheral inflammation to seizure susceptibility: cytokines and brain excitability. Epilepsy Res. 2010, 89:34-42.
152. Rizzi M., Perego C., Aliprandi M., Richichi C., Ravizza T., Colella D., Veliskova J., Moshé S.L., De Simoni M.G., Vezzani A. Glia activation and cytokine increase in rat hippocampus by kainic acid-induced status epilepticus during postnatal development. Neurobiol. Dis. 2003, 14:494-503.
153. Rogers S.W., Andrews P.I., Gahring L.C., Whisenand T., Cauley K., Crain B., Hughes T.E., Heinemann S.F., McNamara J.O. Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis. Science 1994, 265:648-651.
154. Sankar R., Holmes G.L. Mechanisms of action for the commonly used antiepileptic drugs: relevance to antiepileptic drug-associated neurobehavioral adverse effects. J. Child Neurol. 2004, 19(Suppl. 1):S6-S14.
155. Sankar R., Auvin S., Mazarati A., Shin D. Inflammation contributes to seizure-induced hippocampal injury in the neonatal rat brain. Acta Neurol. Scand. 2007, 115:16-20.
156. Scantlebury M.H., Gibbs S.A., Foadjo B., Lema P., Psarropoulou C., Carmant L. Febrile seizures in the predisposed brain: a new model of temporal lobe epilepsy. Ann. Neurol. 2005, 58:41-49.
157. Scantlebury M.H., Heida J.G., Hasson H.J., Veliskova J., Velisek L., Galanopoulou A.S., Moshé S.L. Age-dependent consequences of status epilepticus: animal models. Epilepsia 2007, 48(Suppl. 2):75-82.
158. Scantlebury M.H., Galanopoulou A.S., Chudomelova L., Raffo E., Betancourth D., Moshé S.L. A model of symptomatic infantile spasms syndrome. Neurobiol. Dis. 2010, 37:604-612.
159. Schmitz F., Heit A., Dreher S., Eisenacher K., Mages J., Haas T., Krug A., Janssen K.P., Kirschning C.J., Wagner H. Mammalian target of rapamycin (mTOR) orchestrates the defense program of innate immune cells. Eur. J. Immunol. 2008, 38:2981-2992.
160. Schuchmann S., Tolner E.A., Marshall P., Vanhatalo S., Kaila K. Pronounced increase in breathing rate in the "hair dryer model" of experimental febrile seizures. Epilepsia 2008, 49:926-928.
161. Schwab N., Bien C.G., Waschbisch A., Becker A., Vince G.H., Dornmair K., Wiendl H. CD8+ T-cell clones dominate brain infiltrates in Rasmussen encephalitis and persist in the periphery. Brain 2009, 132:1236-1246.
162. Schwarz J.M., Bilbo S.D. LPS elicits a much larger and broader inflammatory response than Escherichia coli infection within the hippocampus of neonatal rats. Neurosci. Lett. 2011, 497:110-115.
163. Schwarze U., Hahn C., Bengner T., Stodieck S., Buchel C., Sommer T. Enhanced activity during associative encoding in the affected hippocampus in right temporal lobe epilepsy patients. Brain Res. 2009, 1297:112-117.
164. Seifert G., Schilling K., Steinhauser C. Astrocyte dysfunction in neurological disorders: a molecular perspective. Nat. Rev. Neurosci. 2006, 7:194-206.
165. Serdaroglu G., Alpman A., Tosun A., Pehlivan S., Ozkinay F., Tekgul H., Gokben S. Febrile seizures: interleukin 1beta and interleukin-1 receptor antagonist polymorphisms. Pediatr. Neurol. 2009, 40:113-116.
166. Sheedy F.J., O'Neill L.A. Adding fuel to fire: microRNAs as a new class of mediators of inflammation. Ann. Rheum. Dis. 2008, 67(Suppl. 3):50-55.
167. Shlosberg D., Benifla M., Kaufer D., Friedman A. Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury. Nat. Rev. Neurol. 2010, 6:393-403.
168. Singh G., Prabhakar S., Modi M. Central nervous system infections and epilepsy. Epilepsia 2008, 49(Suppl. 6):1.
169. Smith S.E., Li J., Garbett K., Mirnics K., Patterson P.H. Maternal immune activation alters fetal brain development through interleukin-6. J. Neurosci. 2007, 27:10695-10702.
170. Somera-Molina K.C., Robin B., Somera C.A., Anderson C., Stine C., Koh S., Behanna H.A., Van Eldik L.J., Watterson D.M., Wainwright M.S. Glial activation links early-life seizures and long-term neurologic dysfunction: evidence using a small molecule inhibitor of proinflammatory cytokine upregulation. Epilepsia 2007, 48:1785-1800.
171. Song Y.J., Tian X.B., Zhang S., Zhang Y.X., Li X., Li D., Cheng Y., Zhang J.N., Kang C.S., Zhao W. Temporal lobe epilepsy induces differential expression of hippocampal miRNAs including let-7e and miR-23a/b. Brain Res. 2011, 1387:134-140.
172. Spulber S., Bartfai T., Winblad B., Schultzberg M. Morphological and behavioral changes induced by transgenic overexpression of interleukin-1ra in the brain. J. Neurosci. Res. 2011, 89:142-152.
173. Stafstrom C.E. Infantile spasms: a critical review of emerging animal models. Epilepsy Curr. 2009, 9:75-81.
174. Stalder A.K., Carson M.J., Pagenstecher A., Asensio V.C., Kincaid C., Benedict M., Powell H.C., Masliah E., Campbell I.L. Late-onset chronic inflammatory encephalopathy in immune-competent and severe combined immune-deficient (SCID) mice with astrocyte-targeted expression of tumor necrosis factor. Am. J. Pathol. 1998, 153:767-783.
175. Stellwagen D., Beattie E.C., Seo J.Y., Malenka R.C. Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha. J. Neurosci. 2005, 25:3219-3228.
176. Stoll G., Bendszus M. Imaging of inflammation in the peripheral and central nervous system by magnetic resonance imaging. Neuroscience 2009, 158:1151-1160.
177. Taganov K.D., Boldin M.P., Chang K.J., Baltimore D. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:12481-12486.
178. Tarr A.J., McLinden K.A., Kranjac D., Kohman R.A., Amaral W., Boehm G.W. The effects of age on lipopolysaccharide-induced cognitive deficits and interleukin-1beta expression. Behav. Brain Res. 2011, 217:481-485.
179. Tomoum H.Y., Badawy N.M., Mostafa A.A., Harb M.Y. Plasma interleukin-1beta levels in children with febrile seizures. J. Child Neurol. 2007, 22:689-692.
180. Turrin N.P., Gayle D., Ilyin S.E., Flynn M.C., Langhans W., Schwartz G.J., Plata-Salaman C.R. Pro-inflammatory and anti-inflammatory cytokine mRNA induction in the periphery and brain following intraperitoneal administration of bacterial lipopolysaccharide. Brain Res. Bull. 2001, 54:443-453.
181. van Vliet E.A., da Costa Araujo S., Redeker S., van Schaik R., Aronica E., Gorter J.A. Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy. Brain 2007, 130:521-534.
182. Veerhuis R., Nielsen H.M., Tenner A.J. Complement in the brain. Mol. Immunol. 2011, 48:1592-1603.
183. Vezzani A., Conti M., De Luigi A., Ravizza T., Moneta D., Marchesi F., De Simoni M.G. Interleukin-1beta immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures. J. Neurosci. 1999, 19:5054-5065.
184. Vezzani A., Moneta D., Conti M., Richichi C., Ravizza T., De Luigi A., De Simoni M.G., Sperk G., Andell-Jonsson S., Lundkvist J., Iverfeldt K., Bartfai T. Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:11534-11539.
185. Vezzani A., Moneta D., Richichi C., Aliprandi M., Burrows S.J., Ravizza T., Perego C., De Simoni M.G. Functional role of inflammatory cytokines and antiinflammatory molecules in seizures and epileptogenesis. Epilepsia 2002, 43(Suppl. 5):30-35.
186. Vezzani A., Balosso S., Ravizza T. The role of cytokines in the pathophysiology of epilepsy. Brain Behav. Immun. 2008, 22:797-803.
187. Vezzani A., French J., Bartfai T., Baram T.Z. The role of inflammation in epilepsy. Nat. Rev. Neurol. 2011, 7:31-40.
188. Vezzani A., Maroso M., Balosso S., Sanchez M.A., Bartfai T. IL-1 receptor/Toll-like receptor signaling in infection, inflammation, stress and neurodegeneration couples hyperexcitability and seizures. Brain Behav. Immun. 2011, 25(7):1281-1289.
189. Vincent A., Irani S.R., Lang B. The growing recognition of immunotherapy-responsive seizure disorders with autoantibodies to specific neuronal proteins. Curr. Opin. Neurol. 2010, 23:144-150.
190. Virta M., Hurme M., Helminen M. Increased frequency of interleukin-1beta (-511) allele 2 in febrile seizures. Pediatr. Neurol. 2002, 26:192-195.
191. Virta M., Hurme M., Helminen M. Increased plasma levels of pro- and anti-inflammatory cytokines in patients with febrile seizures. Epilepsia 2002, 43:920-923.
192. Viviani B., Bartesaghi S., Gardoni F., Vezzani A., Behrens M.M., Bartfai T., Binaglia M., Corsini E., Di Luca M., Galli C.L., Marinovich M. Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J. Neurosci. 2003, 23:8692-8700.
193. Viviani B., Gardoni F., Marinovich M. Cytokines and neuronal ion channels in health and disease. Int. Rev. Neurobiol. 2007, 82:247-263.
194. Voutsinos-Porche B., Koning E., Kaplan H., Ferrandon A., Guenounou M., Nehlig A., Motte J. Temporal patterns of the cerebral inflammatory response in the rat lithium-pilocarpine model of temporal lobe epilepsy. Neurobiol. Dis. 2004, 17:385-402.
195. Watson R., Jiang Y., Bermudez I., Houlihan L., Clover L., McKnight K., Cross J.H., Hart I.K., Roubertie A., Valmier J., Hart Y., Palace J., Beeson D., Vincent A., Lang B. Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis. Neurology 2004, 63:43-50.
196. Weichhart T., Saemann M.D. The multiple facets of mTOR in immunity. Trends Immunol. 2009, 30:218-226.
197. Wetherington J., Serrano G., Dingledine R. Astrocytes in the epileptic brain. Neuron 2008, 58:168-178.
198. Zattoni M., Mura M.L., Deprez F., Schwendener R.A., Engelhardt B., Frei K., Fritschy J.M. Brain infiltration of leukocytes contributes to the pathophysiology of temporal lobe epilepsy. J. Neurosci. 2011, 31:4037-4050.
199. Zeng L.H., Rensing N.R., Wong M. The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy. J. Neurosci. 2009, 29:6964-6972.
200. Zurolo E., Iyer A., Maroso M., Carbonell C., Anink J.J., Ravizza T., Fluiter K., Spliet G.W.M., van Rijen P.C., Vezzani A., Aronica E. Activation of TLR, RAGE and HMGB1 signaling in malformations of cortical development. Brain 2011, 134:1015-1032.